Cellular inhibition of checkpoint kinase 2 (Chk2) and potentiation of camptothecins and radiation by the novel Chk2 inhibitor PV1019 [7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide] - Jobson, A G; Lountos, G T; Lorenzi, P L (Journal of Pharmacology and Experimental Therapeutics, 2009)
et al.